Medical Supplies Market Restraints
This market is fragmented with various large to small scale players, thus competition is very
high among players to compete with. Vendors continuously cutting prices on legacy products to
retain the market share and support production volume and net profit. Majority of the
disposable products that are not protected by patents are more likely to open to competition.
Thus all these factors may restraint the overall market growth to some extent. To overcome
these factors, competitors need to improve their products that are already present in the market
through technologies and might boost R&D spending to overcome any technology shortcomings.
Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/1633
Medical Supplies Market - Regional Analysis
On the basis of region, global medical supplies market is segmented into North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa. Demand for medical supplies in the
Western Europe, U.S., Japan, and most other developed countries will increase at a slow pace,
as their medical supplies are already well established and have adopted stringent infection
prevention standards to meet the health care needs of people. By contrast, growth in the BRIC
(Brazil, Russia, India, and China) countries and many other emerging economies expected to
spur as health care sectors are modernized, expanding, and adapting to formal infection
prevention protocols.
Medical Supplies Market – Competitive Landscape
Some of the key players operating in the medical supplies market include B. Braun Melsungen
AG, Becton, Dickinson and Company, Cardinal Health, Inc., Halyard Health, Inc., Johnson &
Johnson, Thermo Fisher Scientific Inc., Boston Scientific Corporation, Baxter International Inc.,
and 3M Company among others. Key players are adopting inorganic growth strategies such as
merger and acquisition to retain their position in the market. For instance, in 2017, Becton
Dickinson completed the acquisition of C.R. Bard, Inc., both companies will lead a position to
improve the treatment of disease for patients and the process of care for health care providers.
Furthermore, in April 2018, B. Braun Melsungen AG started five new and enhanced production
plants and other administrative buildings in Penang to manufacture medical devices for infusion
therapy and surgical instruments for the treatment of patients in Malaysia and across the world.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive